References
- Alexander, B. D. and Perfect, J. R., Antifungal resistance trends towards the year 2000 Implications for therapy and new approaches. Drugs, 54, 657-678 (1997) https://doi.org/10.2165/00003495-199754050-00002
- Amyes, S. G. B. and Gemmell, C. G., Antibiotic resistance Proceedings of a symposium held on 12 July 1996 at the University of Southampton. J. Med. Microbiol., 46, 436-470(1997) https://doi.org/10.1099/00222615-46-6-436
- Ates, O., Altintas, H. and Otuk, G., Synthesis and antimicrobial activity of 4-carbethoxymethyl-2-[(alpha-haloacyl)amino]thiazoles and 5-nonsubstituted/stituted 2-[(4-carbethoxy-methylthiazol-2-yl)imino]-4-thiazolidinones. Arzneim. Forsch., 50, 569-575 (2000).
- Cassell, G. H. and Mekalanos, J., Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance. J. Am. Med. Assoc., 285, 601-605 (2001) https://doi.org/10.1001/jama.285.5.601
- Cetinkaya, Y., Falk, P., and Mayhall, C.G., Vancomycin-resistant enterococci. Clin. Microbiol. Rev., 13, 686-707 (2000) https://doi.org/10.1128/CMR.13.4.686-707.2000
- Chu, D. T. W., Plattner, J. J., and Katz, L., New directions in antibacterial research. J. Med. Chem., 39, 3853-3874 (1996) https://doi.org/10.1021/jm960294s
- Cunha, B. A., Antibiotic resistance. Drugs Today, 34, 691-698 (1998) https://doi.org/10.1358/dot.1998.34.8.485267
- Doern, G. V., Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin. lnfect. Dis., 33,187-192 (2001) https://doi.org/10.1086/321812
- Goodman-Gilman, A., The pharmacological basis of therapeutics. McGraw-Hill company, USA, (2001)
- Gringauz, A., Introduction to Medicinal Chemistry, How Drug Act and Why., Wiley-VCH Inc., USA (1997)
- Healy, V. L., Lessard, I. A. D., Roper, D. I., Knox, J. R. and Walsh, C. T., Vancomycin resistance in enterococci: reprogramming of the D-Ala-D-Ala ligases in bacterial peptidoglycan biosynthesis. Chem. Biol., 7, 109-119 (2000) https://doi.org/10.1016/S1074-5521(00)00116-2
- Hood, S. and Denning, D. W., Treatment of fungal infection in AIDS, J. Antimicrob. Chemoth., 37, 71-85 (1996)
- Hubschwerlen, C., Pflieger, P., Specklin, J. L., Gubernator, K., Gmunder, H., Angehrn, P., and Kompis, I., Pyrimido[1,6-a]benzimidazoles: a new class of DNA gyrase inhibitors. J. Med. Chem., 35, 1385-1392 (1992) https://doi.org/10.1021/jm00086a006
- Joule, J. A. and Mills, K., Heterocyclic Chemistry, Blackwell Science Ltd., Oxford, (2000)
- Kim J. S., Sun, Q., Gatto, B., Yu, C., Liu, A., Liu, L. F., and LaVoie, E. J., Structure-activity relationships of benzimidazoles and related heterocycles as topoisomerase I poisons. Bioorg. Med. Chem., 4, 621-630 (1996) https://doi.org/10.1016/0968-0896(96)00047-8
- Koneman, E. W., Allen, S. D., and Winn, W. C., Colour Atlas and Textbook of Diagnostic Microbiology, Lippincott Raven Pub., Philadelphia, (1997)
- Lakhan, R., Sharma, B. P., and Shukla, B. N., Synthesis and antimicrobial activity of 1-aryl-2-amino-3-(4-arylthiazol-2-yl)/(benzothiazol-2-yl)guanidines. Farmaco, 55, 331-337 (2000) https://doi.org/10.1016/S0014-827X(00)00032-X
- Levy, S. B., The challenge of antibiotic resistance. Sci. Am., 278, 46-53 (1998)
- Lipsitch, M., The rise and fall of antimicrobial resistance. Trends Microbiol., 9, 438-444 (2001) https://doi.org/10.1016/S0966-842X(01)02130-8
- Lopez-Garcia, B., Veyrat, A., Perez-Paya, E., Gonzalez-Candelas, L., and Marcos, J. F., Comparison of the activity of antifungal hexapeptides and the fungicides thiabendazole and imazalil against postharvest fungal pathogens. Int. J. Food Microbiol., 89, 163-170, (2003) https://doi.org/10.1016/S0168-1605(03)00118-1
- Marchese, A., Schito, G. C., and Debbia, E. A, Evolution of antibiotic resistance in gram-positive pathogens. J. Chemotherapy, 12, 459-462 (2000) https://doi.org/10.1179/joc.2000.12.6.459
- Onoe, H. and Takahashi, H., Jpn. Kokai. Tokkyo Koho JP 03 87,841 (1994). Chem. Abstr., 121,205336 (1994)
- Pandeya, S. N., Sriram, D., and Nath, G., Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4'-chlorophenyl)thiazol-2-yl] thiosemicarbazide. Eur. J. Pharm. Sci., 9, 25-31 (1999) https://doi.org/10.1016/S0928-0987(99)00038-X
- Perrin, L., Rakik, A., Yerly, S., Baumberger, C., Kinlochde-Loes, S., Pechere, M., and Hirschel, B., Combined therapy with zidovudine and L-697,661 in primary HIV infection. AIDS, 10, 1233-1237 (1996) https://doi.org/10.1097/00002030-199609000-00009
- Rapp, R. P., Antimicrobial resistance in gram-positive bacteria: The myth of the MIC. Pharmacotherapy, 19, 112-119 (1999) https://doi.org/10.1592/phco.19.12.112S.31703
- Rybak, M. J. and Akins, R. L., Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance-Clinical significance and treatment options. Drugs, 6,1-7 (2001) https://doi.org/10.2165/00003495-197306010-00001
- Silverman, R. B., Organic chemistry of Drug Desing and Drug Action, Academic press, San Diego, (1992)
- Thompson, L. A. and Ellman, J. A., Synthesis and applications of small molecule libraries. Chem. Rev., 96, 555-600 (1996) https://doi.org/10.1021/cr9402081
- Turan-Zitouni, G. and Kaplancikli, Z. A., Some new 2,3-dihydro-3-benzofuranamine derivatives. Boll. Chim. Farmaceutico, 137, 367-371 (1998)
- Turan-Zitouni, G., Demirayak, S., Ozdemir, A., Kaplancikli, Z. A., and Yildiz, M. T., Synthesis of some 2-[(benzazole-2yl)thioacetylamino]thiazole derivatives and their antimicrobial activity and toxicity. Eur. J. Med. Chem., 39, 267-272 (2004) https://doi.org/10.1016/j.ejmech.2003.11.001